A Phase II Study of Flavopiridol (Alvocidib) in Combination with Docetaxel in Refractory, Metastatic Pancreatic Cancer-Reference-Cited by-同舟云学术

A Phase II Study of Flavopiridol (Alvocidib) in Combination with Docetaxel in Refractory, Metastatic Pancreatic Cancer

Published:2009-06 Issue:4 Volume:9 Page:404-409
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

Carvajal Richard D.,Tse Archie,Shah Manish A.,Lefkowitz Robert A.,Gonen Mithat,Gilman-Rosen Lisa,Kortmansky Jeremy,Kelsen David P.,Schwartz Gary K.,O'Reilly Eileen M.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference31 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Pancreatic carcinogenesis;Koorstra;Pancreatology,2008

3. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications;Singh;Pancreatology,2007

4. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol,1997

5. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group;Moore;J Clin Oncol,2007

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspectives on chemotherapy-induced toxicities in pancreatic cancer;Current Cancer Reports;2024-02-20

2. Molecular targets that sensitize cancer to radiation killing: From the bench to the bedside;Biomedicine & Pharmacotherapy;2023-02

3. Recent Insights into Therapeutic Potential of Plant-Derived Flavonoids against Cancer;Anti-Cancer Agents in Medicinal Chemistry;2022-12

4. Emerging kinase inhibitors for the treatment of pancreatic ductal adenocarcinoma;Expert Opinion on Emerging Drugs;2022-07-03

5. Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC);Cancers;2021-08-30